PUBLICATIONS (from 2000)

Bakhanashvili M. (2001) Exonucleolytic proofreading by p53 protein. Eur. J.Biochem. 268: 2047-2054.

Bakhanashvili M. (2001) p53  enhances the fidelity of DNA synthesis by human immunodeficiency virus type 1                     reverse transcriptase. Oncogene  20: 7635-7644.

Lilling G, Novitsky E, Sidi Y. and Bakhanashvili M. (2003) p53-associated 3¢®5¢ exonuclease activity in nuclear                   and cytoplasmic compartments of the cells. Oncogene  22, 233-245.   

Kantor R, Bakhanashvili M. and Achiron A. (2003) A mutated CCR5 gene may have favorable clinical and prognostic            implications in multiple sclerosis.  Neurology   61:238-240 

Bakhanashvili M, Novitsky E, Lilling G.  and  Rahav G. (2004) p53 in cytoplasm may enhance the accuracy of DNA               synthesis by  human immunodeficiency virus type 1 reverse transcriptase.  Oncogene 23: 6890-6899.   

Bakhanashvili M, Novitsky E, Levy I and Rahav G.(2005) The fidelity of DNA synthesis by human immunodeficiency             virus type 1 reverse transcriptase increases in the presence of  polyamines.  FEBS  Letters  579: 1435-440.

Bakhanashvili M, Novitsky E, Rubinstein E, Levy I and Rahav G. (2005) Excision of nucleoside analogs from DNA

      by p53 protein: a potential mechanism of resistance to inhibitors of HIV-1 RT.  Antimicriobial Agents and 

      Chemotherapy  49: 1576-1579.

Uziel O, Fenig E, Nordenberg Y, Beery E, Reshef H, Sabndbank J, Birenbaum M, Bakhanashvili M, Yerushalmi R,               Luria D and Lahav M. (2005) Imatinib mesylate (Gleevec) down-regulates telomerase activity and inhibits proliferation           in telomerase expressing cell  lines.   British J  Cancer 92: 1881-1891 

Bakhanashvili M and Rahav G. (2006) A role for tumor suppressor protein p53 in the fidelity of DNA synthesis and                resistance towards nucleoside analogs.  Current Cancer Therapy  Reviews 2: 231-241 

Bakhanashvili M and Rahav G. (2006) The incorporation of nucleoside analogs by human immunodeficiency virus type         1 reverse transcriptase decreases in the presence of polyamines.  FEBS  Letters 580: 5363-5370.

Bakhanashvili M, Gedelovich R, Grinberg S and Rahav G. (2008) Exonucleolytic degradation of RNA by the tumor               suppression protein p53 in cytoplasm.  J Molec. Medicine, 86, 75-88.

Uziel O, Reshef, H, David A, Fabian I, Halperin D, Ram R, Bakhanashvili M, Nordenberg J and Lahav M. (2008).                   Oxidative stress causes telomere damage in fanconi   anemia cells-a possible predisposition for malignant                             transformation.  British J Haematology. 142, 82-93.

Azran-Shaish I, Tabakin-Fix Y, Huleihel M, Bakhanashvili M, and Aboud M. (2008) HTLV-1 Tax-induced NF-kappaB             activation is synergistically enhanced by 12-O-tetra-decanoylphorbol-13-acetate. Mechanism and implications for Tax  pathogenicity. J  Molec. Medicine 86,799-814.

Bakhanashvili M. Grinberg S, Bonda E, Simon AJ, Moshitch-Moshkovitz S and Rahav G. (2008) p53 in mitochondria           enhances the accuracy of DNA synthesis. Cell Death and Differentiation  15, 1865-1874 

Bakhanashvili M. Grinberg S, Bonda E and Rahav G. (2009) Excision of nucleoside analogs in mitochondria by p53              protein.  AIDS 27, 779-788.

Mor R, Uziel O, Shpilberg O, Lahav J, Raanani P, Bakhanashvili M, Rabizadeh E, Zimra Y, Lahav M and Granot G.              (2010) The effect of imatinib mesylate on the signal transduction cascade leading to down regulation of telomerase              activity in K562 cells (BCR-ABL positive cells) and in K562 cells resistant to imatinib mesylate. Experimental                          Hematology 38, 27-37

Bakhanashvili, M, Hizi A and Rahav G. (2010) The interaction of p53 with 3'-terminal mismatched DNA. Cell Cycle               9(7), 1380-1389 Comment in Cell Cycle  News&Views, vol 9(6), page 1030.

Grinberg S, Teiblum G, Rahav G. and Bakhanashvili M. (2010) p53 in cytoplasm exerts 3'®5' exonuclease activity with        dsRNA.  Cell Cycle 9(12), 2442-2455 Comments in Cell Cycle  News&Views, vol 9(13) page 2491 and page 2498.